Mimedx (MDXG) Tax Rate (2013 - 2026)

Mimedx (MDXG) posted Tax Rate of 16.54% for Q2 2026, down 43.3% sequentially from 29.16% in Q1 2026, and down 952.0% YoY from 1.94% in Q2 2025.

Mimedx (MDXG) Tax Rate (2013 - 2026) Analysis & Trends

Mimedx has reported Tax Rate for 14 years, with the latest figure at 16.54% in Q2 2026.

Quarterly Tax Rate fell 952.0% year-over-year to 16.54% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 45.9% (up 1806.0% YoY) and the FY2025 annual result came in at 26.69%, down 1.0% from the prior year.
Tax Rate slipped to 16.54% in Q2 2026 per MDXG's latest filing, from 29.16% in the prior quarter.
Over five years, Tax Rate peaked at 33.88% in Q4 2024 and troughed at 268.63% in Q4 2023.
A 5-year average of 0.59% and a median of 17.49% in 2025 frame the typical range for Tax Rate.
The sharpest annual moves came in 2023 and 2024: Tax Rate tumbled 26892 bps in 2023, then soared 30251 bps in 2024.
Over 5 years, Tax Rate stood at 0.28% in 2022, then plunged by 94678 bps to 268.63% in 2023, then jumped by 113 bps to 33.88% in 2024, then decreased by 11 bps to 30.3% in 2025, then slumped by 45 bps to 16.54% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 16.54%, 29.16%, and 30.3% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Mimedx	622.24 Mn	486.40 Mn	44.38 Mn	16.54%

Download Data